INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
CS
Chen ShipingDirector, Chief Operating Officer
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
247.3K sh
Apr 20, 2026Apr 20, 2026
Page 939 of 1737
← PrevNext →
traded Apr 20, 2026
+0d
SEC Form 4

Evidence

9
LY
Luo YulingDirector, Chief Executive Officer
ALMRAlamar Biosciences, Inc.
Grant or award
A—
76.5K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,888 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
LB
Larson Robert BruceSVP & Chief Accounting Officer
ACIAlbertsons Companies, Inc.
Grant or award
A—
7,636 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,465 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
WM
Withers MichaelEVP Retail Operations West
ACIAlbertsons Companies, Inc.
Grant or award
A—
15.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
YS
Yoon SongyeeDirector
HPQHP INC
Grant or award
A—
12.2K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
WT
West TonySee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,282 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,493 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
KN
Krishnamurthy NikkiSVP and Chief People Officer
UBERUber Technologies, Inc
Option exercise
M—
1,191 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
CS
Chen ShipingDirector, Chief Operating Officer
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
73.2K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
WT
West TonySee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,493 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,465 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
LY
Luo YulingDirector, Chief Executive Officer
ALMRAlamar Biosciences, Inc.
Grant or award
A—
341.2K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
KN
Krishnamurthy NikkiSVP and Chief People Officer
UBERUber Technologies, Inc
Option exercise
M—
1,191 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M—
1,125 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

9
BS
Bhutani Amanpal SinghDirector
NYTNEW YORK TIMES CO
Grant or award
A—
81 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
LB
Larson Robert BruceSVP & Chief Accounting Officer
ACIAlbertsons Companies, Inc.
Grant or award
A—
7,636 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,493 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
RE
Rainwater EvanEVP, Supp. Chain, Mfg. & Sourc
ACIAlbertsons Companies, Inc.
Grant or award
A—
17.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
MS
Mccollam SharonPresident & CFO
ACIAlbertsons Companies, Inc.
Grant or award
A—
42.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
MM
Moriarty Thomas MEVP, M&A and Corporate Affairs
ACIAlbertsons Companies, Inc.
Option exercise
M—
110.0K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
KA
Krishnamurthy Balaji (A)Chief Financial Officer
UBERUber Technologies, Inc
Option exercise
M—
606 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
2,472 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
WM
Withers MichaelEVP Retail Operations West
ACIAlbertsons Companies, Inc.
Grant or award
A—
15.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M—
360 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
WT
West TonySee Remarks
UBERUber Technologies, Inc
Option exercise
M—
2,910 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
CG
Clark Joseph GatesSVP and Pres, Optimized LED
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$134K
5,000 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
WT
West TonySee Remarks
UBERUber Technologies, Inc
Tax withholding
F$49K
636 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
WM
Withers MichaelEVP Retail Operations West
ACIAlbertsons Companies, Inc.
Grant or award
A—
15.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
MJ
McAnear Justin J.Chief Financial Officer
ALMRAlamar Biosciences, Inc.
Grant or award
A—
37.2K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
KN
Krishnamurthy NikkiSVP and Chief People Officer
UBERUber Technologies, Inc
Tax withholding
F$36K
476 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
LY
Luo YulingDirector, Chief Executive Officer
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
1.22M sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
VR
Van Dyck RebeccaDirector
NYTNEW YORK TIMES CO
Grant or award
A—
151 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
MM
Moriarty Thomas MEVP, M&A and Corporate Affairs
ACIAlbertsons Companies, Inc.
Grant or award
A—
36.7K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
MS
Morris SusanDirector, Chief Executive Officer
ACIAlbertsons Companies, Inc.
Grant or award
A—
112.1K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
LM
Larson MichelleChief Merchandising Officer
ACIAlbertsons Companies, Inc.
Grant or award
A—
35.6K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
BR
Backus RobertEVP Retail Operations East
ACIAlbertsons Companies, Inc.
Grant or award
A—
15.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
LY
Luo YulingDirector, Chief Executive Officer
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
880.8K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
2,520 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence